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Two strains of lymphocytic choriomeningitis virus obtained in 1935 
from naturally infected stock mice have been used for experimental 
work  in  this  laboratory.  These  strains  were  highly  virulent  for 
guinea pigs when isolated.  The present paper deals with the effect 
on the virus of serial passage through guinea pigs and mice and the 
use of a  modified strain as an immunizing agent for guinea pigs. 
The Strains Employed 
Strain A, which was used in most of the experiments reported in previous papers 
(1, 2), showed no marked change in the course of 8 serial passages  through guinea 
pigs by subcutaneous  injection 1 or 10 serial transfers  in virus-free mice by intra- 
cerebral  inoculation.  The  mouse  passages  were  discontinued  after  the  10th 
transfer,  but the guinea pig passage strain has been maintained. 
Strain B was obtained from two guinea pigs, both of which developed  severe 
choriomeningltis  after intracerebral  inoculation  with the brain of a  mouse and 
were killed when moribund on the 12th or 13th day.  Virus from their brains  has 
thus  far been passed in series through 14 guinea pigs by subcutaneous  injection 
and in  another series  through 34 virus-free  mice  by intracerebral  inoculation. 
Brain suspensions were used for subinoculation  in guinea pigs and mice. 
Effect on Strain t3 of Serial Passage through Guinea Pigs 
The transfers through guinea pigs have maintained the high viru- 
lence of strain B  for this species.  Subcutaneous or intracerebral in- 
jections are usually fatal, even when very small amounts of virus are 
given, such as 1 to 10 minimal infective doses (~x.I.D.), and the guinea 
1 Subcutaneous  inoculations were made into the metatarsal pads. 
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pigs that do not die develop a very severe disease with marked emacia- 
tion and slow recovery. 
All mice injected intracerebrally with this strain become sick, but 
many of them survive and fail to show the striking convulsions which 
characterize the disease induced by intracerebral injection with the 
mouse passage strain.  Intravenous or intraperitoneal injection causes 
illness in the majority of the mice, but the rate of mortality is con- 
siderably lower than after intracerebral inoculation.  Subcutaneous 
injection and intranasal instillation produce no  symptoms and yet 
render mice resistant to intracerebral inoculation.  The virus can be 
demonstrated in the blood of infected mice and occasionally persists 
in it for more than a month after recovery. 
Effect on Strain B of Serial Passage through Mice 
The results of intracerebral tests show that too.use passage has in- 
creased the  virulence of  strain B  for  mice.  Subclinical infections 
occasionally  occurred  in the early passages even when  large amounts of 
virus were inoculated, but injections with more than 10 ~.I.D. of virus 
from the later passages caused typical convulsions and death on the 
6th or 7th day in nearly 100 per cent of the mice.  Doses near the 
borderline of infectivity, however, occasionally produced immunity 
without  apparent  symptoms.  Intravenous,  intraperitoneal,  subcu- 
taneous, or intranasal inoculations of virus from the later passages 
have failed to cause any definite signs of illness, but have immunized 
against intracerebral injection with virus.  The blood of three mice 
injected intracerebrally was infectious when symptoms were mani- 
fest, but the virus was not demonstrated in the blood in repeated 
tests made 1 month after inoculation. 
The pathogenicity of the mouse passage strain for guinea pigs has 
greatly decreased.  It is not known exactly when this loss of virulence 
occurred; brain suspension from the 8th serial transfer was avirulent 
for guinea pigs.  Intracerebral injections of this modified virus are 
followed by fever lasting several days and no other sign  of disease. 
Some guinea pigs  do  not  gain weight during the febrile period as 
rapidly as uninjected controls, but to an uninformed observer they 
do not appear ill.  None of the symptoms that characterize the in- 
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as  labored  respiration,  drowsiness,  salivation,  vomiting,  conjuncti- 
vitis, and emaciation, have been noted, and all of the 53 guinea pigs 
injected either intracerebrally or subcutaneously survived.  Subcu- 
taneous inoculations cause fever in the majority of the cases, but it 
is usually lower and of shorter duration than that induced by intra- 
cerebral injection.  The amount of virus inoculated either intracere- 
brally or subcutaneously did not markedly influence the reaction of 
the animals.  The blood contained virus during the febrile reaction 
on the 7th day after injection in two guinea pigs tested. 
The virulence of the modified strain for guinea pigs was not re- 
stored by a  single guinea pig passage, no matter whether blood or 
brain  was  used for  subinoculation.  Intracerebral  or  subcutaneous 
injection with  a  mixture of mouse brain  containing modified virus 
and guinea pig brain in which the virulent strain had been inactivated 
by heating at 70°C.  for 1/6 hour, likewise failed to increase the viru- 
lence of the modified strain.  Nor has it been possible to modify the 
virulent guinea pig passage strain by one or two intracerebral pas- 
sages through mice.  This fact indicates that the modification of the 
mouse strain probably did not take place during the first two serial 
transfers in mice. 
In the following section of the paper the strain B passed through 
mice and attenuated for guinea pigs will be  called "mouse virus," 
while the strains  A  and B  passed through guinea pigs and highly 
virulent for  this  species will be  referred to  as  "guinea pig virus." 
For immunity tests with  guinea pigs,  strains  A  and B  were often 
mixed to insure a  high degree of virulence in the inoculum. 
Immunization of Guinea Pigs with Mouse Virus 
A single intracerebral or subcutaneous injection with mouse virus 
was sufficient to induce a high degree of resistance to intracerebral or 
subcutaneous inoculation with a  large amount of guinea pig virus, 
such as 0.1  or 0.5  cc.  of a  10 per cent guinea pig brain suspension, 
given 3 weeks later.  The development of fever in some guinea pigs 
following  subcutaneous inoculation  apparently  had  no  relation  to 
the degree of immunity produced. 
The immunity arose rapidly as Table I  shows.  Subcutaneous in- 
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a similar  injection  of guinea pig virus  into  the right hind pad failed 
to prevent the disease induced by the latter strain, but there is evi- 
TABLE  I 
Immunity of Guinea Pigs in Relation to Circulating Antivirus 
tion with 
i  i~louse 
virus 
$c 
SC 
sc 
sc 
ic 
~JulL ~ 
pig ~ [O. 
1 
2 
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4 
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Test of immunity by injection with guinea pig virus 
Time after  Route  Controls 
inoculation  of  Reaction 
with mouse  inocu- 
virus  lation 
1 rain.  sc 
4 days  sc 
8 days  ic 
10 days  ic 
No.  Reaction 
D 11  17  D 14 
D 13  18  D 15 
D 27  19  D 9 
Mild  disease,  20  D 11 
rapid recovery 
Severe  disease,  21  ]  D 14 
slow recovery 
Fever 
Mild  disease, 
rapid recovery 
22  D 12 
23  D 12 
Slight fever  24--27  D 11-15 
None 
None  28--30 Very  severe  dis- 
ease, slow re- 
covery 
Slight fever 
Slight fever 
None 
None 
None 
None 
31  D 11 
32  D 12 
sc -- subcutaneously. 
ic =  intracerebrally. 
D 11  -- diedon llth day. 
-  -- no antivirus  detected. 
-k -- antivlrus  probably present. 
dence that  its  course  was  modified in two  animals (Nos.  4  and 5). 
On the 4th day a  degree of resistance was apparent, and on the 8th 
or 10th day, 6 of the 9 guinea pigs tested  were  completely  resistant, E~C~  TgAUB  321 
while the remainder developed a transient fever.  Other guinea pigs not 
recorded in the table, which were tested for immunity by intracerebral 
inoculation on the  18th,  21st,  or 31st day after subcutaneous or in- 
tracerebral injection with mouse virus, were all completely resistant. 
The  Relation of Circulating Antivirus  to  the  Immunity  of Guinea 
Pigs.--The failure  to  detect  circulating  antivirus  in mice possessing 
a high degree of immunity to choriomeningitis was reported in a previ- 
ous communication  (1).  Numerous other sera from mice immunized 
or hyperimmunized  by a  variety of methods have since been tested 
but none of them had definite neutralizing  power.  If antivirus  was 
present, its concentration was too low to account for the high degree 
of resistance  shown by the mice.  Extracts  of the brains and livers 
of mice that  had become resistant  to intracerebral  injection by sub- 
cutaneous inoculation  with  mouse virus likewise failed to  give any 
evidence of an antiviral substance.  The sera of immune guinea pigs, 
on  the  other  hand,  usually  contained  antivirus  when  tested  a  few 
weeks after recovery. 
Because of this apparent difference in mechanism between the im- 
munity  of mice  and  that  of guinea  pigs,  an  attempt  was made  to 
determine whether the immunity of the latter was due solely to cir- 
culating  antivirus  or,  as in mice, to another  factor as yet unknown 
but closely associated with the tissues affected by the virus. 
A number of guinea pigs injected subcutaneously or intracerebraUy with mouse 
virus were bled by heart puncture under deep ether anesthesia a few hours before 
they were tested for immunity as indicated in Table I.  The sera obtained were 
avirulent for mice, except that of guinea pig 11 which produced the disease in one 
of the two mice inoculated.  Neutralization  tests were performed with  the sera 
according to the method already described (1). 
The results of the tests recorded in Table I  indicate that the high 
degree of immunity present on the 8th and the 10th day after injec- 
tion was not associated with demonstrable antivirus  in the majority 
of the animals.  Other guinea pig sera drawn 1 month after injection 
with mouse virus had definite neutralizing  properties. 
DISCUSSION 
Strains  of  choriomeningitis  virus  isolated  in  earlier  experiments 
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pigs although similar in every other respect.  Some caused merely a 
febrile reaction in the majority of the animals, while others induced 
a very severe, fatal disease.  However, not one of the strains of low 
virulence was quite consistent in its effect,  a fatal disease sometimes 
resulting with those that were relatively non-pathogenic.  The vari- 
ations in severity of the disease were thought to be mainly due to dif- 
ferences in the susceptibility of guinea pigs, and this assumption was 
supported by the fact that the virus obtained from the same mouse 
at different times was differently pathogenic for guinea pigs (1, Table 
III).  However, the rapid and striking change of strain B  brought 
about by a few serial passages through mice now suggests that varia- 
tions of the virus may be in part responsible for those differences.  It 
has been shown that guinea pigs from the same stock as those used 
before react uniformly both to the guinea pig passage strain, which 
invariably causes very severe choriomeningitis, fatal in 80 to 90 per 
cent of the cases, and to the modified mouse strain, which has failed 
to produce symptoms in any of the 53 guinea pigs injected. 
The modified virus is a very good immunizing agent for guinea pigs, 
since it is harmless to the animals and produces a  solid immunity 
after a  single injection. 
The immunity to choriomeningitis of guinea pigs and mice differs 
in that immune guinea pigs as a  rule develop circulating antivirus, 
whereas the sera from immune mice thus far tested have had no defi- 
nite  neutralizing properties.  The comparatively late appearance of 
the antivirus in the guinea pig indicates, however, that it does not 
solely account for their immunity, which seems to be closely associ- 
ated  with  the  tissues  affected by  the  virus.  Similar observations 
have been reported for other viruses, for  example,  foot-and-mouth 
disease  (3)  and  poliomyelitis  (4-6).  The  possibility  of  infecting 
immune animal tissues in vitro with a  variety of viruses, e.g.,  virus 
III (7),  vaccinia (8),  herpes simplex (9),  the salivary gland virus of 
guinea pigs  (10),  and pseudorabies  (11),  does not necessarily weigh 
against  this  conception  of  the  mechanism of  antiviral  immunity. 
The  washing  and  soaking  of  the  tissue  fragments,  which usually 
preceded the infection in such experiments, may have removed an 
antiviral substance that was fixed in the tissues or rendered it ineffec- ~.P.ICH ~UB  323 
five by dilution.  The evidence thus far obtained with tissue extracts 
from immune mice does not favor the assumption that  such a  sub- 
stance is present, but further tests are necessary to disprove its exist- 
ence.  It  is  also possible that  the  removal of the  tissue  from  its 
physiological environment and its maintenance under extremely un- 
favorable conditions alter the permeability to viruses of the cellular 
membrane.  This permeability may provide the  basis  of  suscepti- 
bility and immunity. 
SUMM~Ry 
A  strain  of choriomeningitis virus which was  highly virulent for 
guinea pigs,  as isolated from a  naturally infected white mouse, has 
been  markedly  attenuated  for  guinea  pigs  by  serial  intracerebrai 
passage through white mice.  The change of virulence occurred be- 
fore the 8th serial passage.  The modified virus as a  rule produces 
fever in  guinea pigs but  no other symptoms, and the infection is 
followed by a  very solid immunity.  Parallel passages of the same 
strain  through guinea pigs have maintained its  high virulence for 
this species but slightly reduced its pathogenicity for mice.  These 
observations indicate that the differences in virulence for guinea pigs 
noted before  (1,  2)  with  different strains of choriomeningitis virus 
obtained from infected stock mice may be due not only to differences 
in the susceptibility of guinea pigs but also to variations in the viru- 
lence of the virus. 
A marked degree of resistance was demonstrable in several guinea 
pigs on the 4th, 8th, and 10th day after injection with modified virus, 
when antivirus could not yet be detected in the serum.  Circulating 
antivirus appears therefore to play a secondary part in their {mmunity, 
which seems to be closely associated with the tissues as in mice. 
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